Trial intelligence / Profile preview

Bioequivalence study of 100 mg lacosamide tablets in healthy Thai volunteers

TCTR20201028003Completed

Sponsor
All Research
Start
Jan 2021
Modality
Small Molecules
Countries
1
01

Overview

Randomised, open-label trial of lacosamide (2 arms), sponsored by All Research. Primary endpoints: Cmax, AUC0-t and 1 more. Started Jan 2021; status: completed.

02

Drugs

lacosamide

Beyond the preview

Go deeper on TCTR20201028003.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20201028003.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call